Annual report pursuant to Section 13 and 15(d)

Iloperidone Sublicense (Details Textual)

v3.8.0.1
Iloperidone Sublicense (Details Textual)
12 Months Ended
Dec. 31, 2017
Minimum [Member]  
Operating Leased Assets [Line Items]  
Percentage Of Next Slab Of Annual Sales For Calculating Net Royalty 8.00%
Maximum [Member]  
Operating Leased Assets [Line Items]  
Percentage Of Next Slab Of Annual Sales For Calculating Net Royalty 10.00%